Navigation Links
Reportlinker Adds Global Pharmaceutical Contract Manufacturing Industry
Date:2/22/2011

NEW YORK, Feb. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Pharmaceutical Contract Manufacturing Industry

http://www.reportlinker.com/p098296/Global-Pharmaceutical-Contract-Manufacturing-Industry.html

This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Million by the following Dosage Forms: Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid Dosage Forms (Syrups and Suspensions). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 82 companies including many key and niche players such as Althea Technologies, Catalent Pharma Solutions, Dishman Pharmaceuticals and Chemicals Ltd., HAUPT Pharma AG, Jubilant Organosys Ltd., Kemwell Pvt. Ltd., NextPharma, Nipro Corp., Patheon, Inc., Penn Pharmaceutical Services Ltd., and Royal DSM N.V. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

To order this report:: Global Pharmaceutical Contract Manufacturing Industry

More  Market Research Report

Check our
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
2. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
3. Reportlinker Adds The U.S. Medical Laboratories Industry - 10th Edition
4. Reportlinker Adds Drug Device Combination Market to 2016 - Technological Convergence to be the New Business Model for Growth and Profitability
5. Reportlinker Adds Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
6. Reportlinker Adds Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment
7. Reportlinker Adds Anti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials Market
8. Reportlinker Adds Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets
9. Reportlinker Adds Manufacturing of Solid Dosage Forms - 2011
10. Reportlinker Adds Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
11. Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... its new YouTube video, “Fireside Convalescent Care Center.” The video informs community members ... video after continually seeing the need for those seeking care to be well ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... premier event and tradeshow, taking place July 29 to August 1. Retail Management ... , ThoughtSpot is a four-day event for independent community pharmacies, where ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June ... $3.1 million grant to study how sensory stimuli can be used to “decrease children’s ... improving care for children with autism, will compare patient experience in a “typical dental ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... Successfully treating and reversing the effects of multiple sclerosis, ... drug originally developed to treat chronic pain, according to ... at Boulder. Watkins and her colleagues in CU-Boulder,s ... injection of a compound called ATL313 -- an anti-inflammatory ...
... Taking time off from certain osteoporosis drugs may be beneficial ... University Health System. Researchers found that bone density remained stable ... from bisphosphonates, a popular class of osteoporosis drugs that can ... the jaw bone. "These drugs are potentially harmful when ...
... at the Harvard School of Public Health (HSPH) and Knowledge ... or cancer believe the economic downturn is hurting their health ... Many Americans with these illnesses face financial problems paying for ... do not believe the new national health care reform law ...
... 18 (HealthDay News) -- A brain area that plays an ... separately to different colors, a new animal study has found. ... could help improve understanding of perception and attention, said the ... "In vision, objects are defined by both their shape ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Nov. ... as an example, new research finds that doctors, prescribing patterns ... from the U.S. Food and Drug Administration. The ... of risk depending on where they live, the researchers said. ...
... D receptors on cancer cells has prompted encouraging responses ... men with prostate cancer that has become resistant to ... clinical trial will be presented at the 22nd EORTC-NCI-AACR ... Berlin today (Thursday). The trial found that when the ...
Cached Medicine News:Health News:Laboratory studies show promise for new multiple sclerosis treatment 2Health News:Taking a break from osteoporosis drugs can protect bones 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 3Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 4Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 2Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 3Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 2Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 3
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: